Searchable abstracts of presentations at key conferences in endocrinology

ea0063p471 | Calcium and Bone 2 | ECE2019

Parathyroid hormone (PTH) levels are not associated with cancer in patients with primary hyperparathyroidism

Boutzios Georgios , Tomara Nefeli , Kotsifa Eugenia , Koukoulioti Eleni , Garoufalia Zoe , Spartalis Elefterios , Tsourouflis Gerasimos

Introduction: The development of malignancies in patients with Primary Hyperparathyroidism (PHP) occurs in the context of Multiple Endocrine Neoplasia (MEN) Syndrome. The association of PTH levels with cancer in patients with sporadic PHP has not been clarified. The aim of this study was to investigate whether PTH levels are related to the presence of thyroid cancer (TH) or other types of cancer in patients with PHP.Methods: We included patients with bio...

ea0063p784 | Thyroid 2 | ECE2019

The association between the levels of the TSI antibodies and thyroid cancer among patients with Graves’ disease who have undergone total thyroidectomy

Boutzios Georgios , Kotsifa Eugenia , Tomara Nefeli , Koukoulioti Eleni , Garoufalia Zoe , Spartalis Elefterios , Tsourouflis Gerasimos

Introduction: TSI (Thyroid Stimulating Immunoglobulin) antibodies are a form of immunoglobulin G (IgG) that can bind to thyrotropin receptors on the thyroid gland causing over-production of thyroid hormones and hyperthyroidism. The presence of positive TSI is considered pathognomonic for GravesÂ’ disease. Although the association between GravesÂ’ disease and thyroid cancer (TC) has been reported in previous studies, the association between the levels of TSI antibodies ...